Trials / Unknown
UnknownNCT05064852
A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective, single-arm, open-label,multi-center, observational real-world clinical study to observe and evaluate the efficacy and safety of Surufatinib in the treatment of patients with biliary tract cancer (BTC).
Detailed description
This is a prospective, single-arm, open-label,multi-center, observational real-world clinical study to observe and evaluate the efficacy and safety of Surufatinib in the treatment of patients with biliary tract cancer (BTC). About 200 subjects are prepared to recruit in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Surufatinib | The study is a real-world study. According to the actual medical history of patients, the usage of Surufatinib was collected. |
Timeline
- Start date
- 2021-09-20
- Primary completion
- 2022-12-20
- Completion
- 2023-12-20
- First posted
- 2021-10-01
- Last updated
- 2021-10-01
Source: ClinicalTrials.gov record NCT05064852. Inclusion in this directory is not an endorsement.